Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR3 | P29371 | 16/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.39 |
| ▸ | TACR2 | P21452 | 1/20 | 0.37 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4963763 | 0.91 | TACR3 (0.45) | TACR3CYP3A4KCNH2TACR2PDE10A | |
| SCHEMBL4962074 | 0.91 | TACR3 (0.48) | TACR3CYP3A4KCNH2TACR2PDE10A | |
| SCHEMBL4963861 | 0.88 | TACR3 (0.47) | TACR3CYP3A4KCNH2TACR2PDE10A | |
| SCHEMBL4963089 | 0.86 | TACR3 (0.50) | TACR3CYP3A4KCNH2TACR2PDE10A | |
| SCHEMBL4961924 | 0.81 | TACR3 (0.46) | TACR3CYP3A4KCNH2TACR2PDE10A | |
| SCHEMBL4961950 | 0.80 | TACR3 (0.54) | TACR3CYP3A4KCNH2 | |
| SCHEMBL4964873 | 0.80 | TACR3 (0.51) | TACR3 | |
| SCHEMBL4962167 | 0.77 | TACR3 (0.53) | TACR3CYP3A4 | |
| SCHEMBL4966091 | 0.77 | TACR3 (0.68) | TACR3CYP3A4TACR2 | |
| SCHEMBL4961879 | 0.77 | TACR3 (0.68) | TACR3CYP3A4TACR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1896418-A1 | QUINOLINE 3 -SULFONATE ESTERS AS NK3 RECEPTOR MODULATORS | AstraZeneca AB (SE) | 2008-03-12 | — | — | EP | claimed |
| WO-2006137789-A1 | Quinoline 3 -sulfonate esters as NK3 receptor modulators | ASTRAZENECA AB (SE) | 2006-12-28 | — | — | WO | claimed |
| EP-1896418-A1 | QUINOLINE 3 -SULFONATE ESTERS AS NK3 RECEPTOR MODULATORS | AstraZeneca AB (SE) | 2008-03-12 | — | — | EP | disclosed |
| WO-2006137789-A1 | Quinoline 3 -sulfonate esters as NK3 receptor modulators | ASTRAZENECA AB (SE) | 2006-12-28 | — | — | WO | disclosed |